Mint Tower Capital Management B.V. »

Fusion Pharmaceuticals shares owned by Mint Tower Capital Management B.V.

Quarter-by-quarter ownership of Fusion Pharmaceuticals (FUSN) shares owned by Mint Tower Capital Management B.V. from 13F filings

Historical chart of Mint Tower Capital Management B.V. investment in Fusion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Fusion Pharmaceuticals held by Mint Tower Capital Management B.V. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fusion Pharmaceuticals by Mint Tower Capital Management B.V.

Quarter filed Position value Share count Share price at filing
2024-03-31 $533k 25k 21.32

More positions owned by Mint Tower Capital Management B.V.

Royal Caribbean Group Note 6.000% 8/1 (Principal)
On Semiconductor Corp Note5/0 (Principal)
On Semiconductor Corp Note 0.500% 3/0 (Principal)
Splunk Note 1.125% 6/1 (Principal)
Lantheus Hldgs Note 2.625%12/1 (Principal)
Microstrategy Note2/1 (Principal)
Morgan Stanley Put Option (MS)
Ionis Pharmaceuticals Note4/0 (Principal)
Alnylam Pharmaceuticals Note 1.000% 9/1 (Principal)
Exxon Mobil Corporation Put Option (XOM)
Sarepta Therapeutics Note 1.250% 9/1 (Principal)
Apple (AAPL)
Li Auto Note 0.250% 5/0 (Principal)
Hess (HES)
Churchill Capital Corp Vii Com Cl A (CVII)

View all positions for Mint Tower Capital Management B.V.

Top funds holding Fusion Pharmaceuticals

Federated Investors
Perceptive Advisors
Avidity Partners Management
Deerfield Management Company
Fil
Pentwater Capital Management
Johnson & Johnson
Millennium Management
Tpg Gp A
TIG Advisors
FMR
Marshall Wace
Verition Fund Management
Qube Research & Technologies
William Blair $ Company

View all funds holding Fusion Pharmaceuticals